221 related articles for article (PubMed ID: 10439881)
1. Low-dose glucose-insulin-potassium is ineffective in acute myocardial infarction: results of a randomized multicenter Pol-GIK trial.
Ceremuzyński L; Budaj A; Czepiel A; Burzykowski T; Achremczyk P; Smielak-Korombel W; Maciejewicz J; Dziubińska J; Nartowicz E; Kawka-Urbanek T; Piotrowski W; Hanzlik J; Cieśliński A; Kawecka-Jaszcz K; Gessek J; Wrabec K
Cardiovasc Drugs Ther; 1999 May; 13(3):191-200. PubMed ID: 10439881
[TBL] [Abstract][Full Text] [Related]
2. [Effect of high dose glucose-insulin-potassium infusion in patients with acute ST-segment elevation myocardial infarction: analysis of 7510 patients in China as part of CREATE-ECLA study].
Yang YM; Zhu J; Tan HQ; Liang Y; Zhang Y; Li Y; Li JD; Liu LS;
Zhonghua Yi Xue Za Zhi; 2008 Jul; 88(26):1806-10. PubMed ID: 19040013
[TBL] [Abstract][Full Text] [Related]
3. Effect of glucose-insulin-potassium infusion on mortality in patients with acute ST-segment elevation myocardial infarction: the CREATE-ECLA randomized controlled trial.
Mehta SR; Yusuf S; Díaz R; Zhu J; Pais P; Xavier D; Paolasso E; Ahmed R; Xie C; Kazmi K; Tai J; Orlandini A; Pogue J; Liu L;
JAMA; 2005 Jan; 293(4):437-46. PubMed ID: 15671428
[TBL] [Abstract][Full Text] [Related]
4. Glucose-insulin-potassium therapy in patients with ST-segment elevation myocardial infarction.
Díaz R; Goyal A; Mehta SR; Afzal R; Xavier D; Pais P; Chrolavicius S; Zhu J; Kazmi K; Liu L; Budaj A; Zubaid M; Avezum A; Ruda M; Yusuf S
JAMA; 2007 Nov; 298(20):2399-405. PubMed ID: 18042917
[TBL] [Abstract][Full Text] [Related]
5. Effect of glucose-insulin-potassium infusion on myocardial damage due to percutaneous coronary revascularization.
Yazici M; Demircan S; Durna K; Yasar E; Acar Z; Sahin M
Am J Cardiol; 2005 Dec; 96(11):1517-20. PubMed ID: 16310433
[TBL] [Abstract][Full Text] [Related]
6. Out-of-hospital administration of intravenous glucose-insulin-potassium in patients with suspected acute coronary syndromes: the IMMEDIATE randomized controlled trial.
Selker HP; Beshansky JR; Sheehan PR; Massaro JM; Griffith JL; D'Agostino RB; Ruthazer R; Atkins JM; Sayah AJ; Levy MK; Richards ME; Aufderheide TP; Braude DA; Pirrallo RG; Doyle DD; Frascone RJ; Kosiak DJ; Leaming JM; Van Gelder CM; Walter GP; Wayne MA; Woolard RH; Opie LH; Rackley CE; Apstein CS; Udelson JE
JAMA; 2012 May; 307(18):1925-33. PubMed ID: 22452807
[TBL] [Abstract][Full Text] [Related]
7. The beneficial effect of insulin, glucose, and dipyridamole on regional left ventricular function early after acute myocardial infarction.
Bedetti G; Pizzi C; Gabrieli L; Varga A; Pasanisi E; Bugiardini R; Picano E
Int J Cardiol; 2005 Jul; 102(2):255-8. PubMed ID: 15982493
[TBL] [Abstract][Full Text] [Related]
8. Glucose-insulin-potassium and tri-iodothyronine individually improve hemodynamic performance and are associated with reduced troponin I release after on-pump coronary artery bypass grafting.
Ranasinghe AM; Quinn DW; Pagano D; Edwards N; Faroqui M; Graham TR; Keogh BE; Mascaro J; Riddington DW; Rooney SJ; Townend JN; Wilson IC; Bonser RS
Circulation; 2006 Jul; 114(1 Suppl):I245-50. PubMed ID: 16820580
[TBL] [Abstract][Full Text] [Related]
9. High-dose glucose-insulin-potassium treatment reduces myocardial apoptosis in patients with acute myocardial infarction.
Zhang L; Zhang L; Li YH; Zhang HY; Chen ML; Gao MM; Hu AH; Yang HS; Yang HS
Eur J Clin Invest; 2005 Mar; 35(3):164-70. PubMed ID: 15733070
[TBL] [Abstract][Full Text] [Related]
10. Cardioprotective Effects of Glucose-Insulin-Potassium Infusion in Patients Undergoing Cardiac Surgery: A Systematic Review and Meta-Analysis.
Hagerman A; Schorer R; Putzu A; Keli-Barcelos G; Licker M
Semin Thorac Cardiovasc Surg; 2024 Summer; 36(2):167-181. PubMed ID: 36356908
[TBL] [Abstract][Full Text] [Related]
11. Effects of glucose-insulin-potassium solution added to reperfusion treatment in acute myocardial infarction.
Türel B; Gemici K; Baran I; Yeşilbursa D; Güllülü S; Aydinlar A; Serdar A; Kazazoğlu AR; Kumbay E; Cordan J
Anadolu Kardiyol Derg; 2005 Jun; 5(2):90-4. PubMed ID: 15939681
[TBL] [Abstract][Full Text] [Related]
12. Study design for the Immediate Myocardial Metabolic Enhancement During Initial Assessment and Treatment in Emergency Care (IMMEDIATE) Trial: A double-blind randomized controlled trial of intravenous glucose, insulin, and potassium for acute coronary syndromes in emergency medical services.
Selker HP; Beshansky JR; Griffith JL; D'Agostino RB; Massaro JM; Udelson JE; Rashba EJ; Ruthazer R; Sheehan PR; Desvigne-Nickens P; Rosenberg YD; Atkins JM; Sayah AJ; Aufderheide TP; Rackley CE; Opie LH; Lambrew CT; Cobb LA; Macleod BA; Ingwall JS; Zalenski RJ; Apstein CS
Am Heart J; 2012 Mar; 163(3):315-22. PubMed ID: 22424000
[TBL] [Abstract][Full Text] [Related]
13. Modified Glucose-Insulin-Potassium Regimen Provides Cardioprotection With Improved Tissue Perfusion in Patients Undergoing Cardiopulmonary Bypass Surgery.
Zhao K; Zhang Y; Li J; Cui Q; Zhao R; Chen W; Liu J; Zhao B; Wan Y; Ma XL; Yu S; Yi D; Gao F
J Am Heart Assoc; 2020 Mar; 9(6):e012376. PubMed ID: 32151220
[TBL] [Abstract][Full Text] [Related]
14. Glucose-insulin-potassium infusion as adjunctive therapy in myocardial infarction: current evidence and potential mechanisms.
Timmer JR; van der Horst IC; Ottervanger JP; De Luca G; van 't Hof AW; Bilo HJ; Zijlstra F
Ital Heart J; 2004 Oct; 5(10):727-31. PubMed ID: 15626267
[TBL] [Abstract][Full Text] [Related]
15. The impact of glucose-insulin-potassium infusion in acute myocardial infarction on infarct size and left ventricular ejection fraction [ISRCTN56720616].
van der Horst IC; Ottervanger JP; van 't Hof AW; Reiffers S; Miedema K; Hoorntje JC; Dambrink JH; Gosselink AT; Nijsten MW; Suryapranata H; de Boer MJ; Zijlstra F
BMC Med; 2005 Jun; 3():9. PubMed ID: 15932638
[TBL] [Abstract][Full Text] [Related]
16. Effects of glucose-insulin-potassium infusion on ST-elevation myocardial infarction in patients treated with thrombolytic therapy.
Krljanac G; Vasiljević Z; Radovanović M; Stanković G; Milić N; Stefanović B; Kostić J; Mitrović P; Radovanović N; Dragović M; Marinković J; Karadzić A
Am J Cardiol; 2005 Oct; 96(8):1053-8. PubMed ID: 16214437
[TBL] [Abstract][Full Text] [Related]
17. Reduction of hospital mortality rate of acute myocardial infarction with glucose-insulin-potassium infusion.
Rogers WJ; Stanley AW; Breinig JB; Prather JW; McDaniel HG; Moraski RE; Mantle JA; Russell RO; Rackley CE
Am Heart J; 1976 Oct; 92(4):441-54. PubMed ID: 785990
[TBL] [Abstract][Full Text] [Related]
18. Metabolic modulation of acute myocardial infarction. The ECLA (Estudios Cardiológicos Latinoamérica) Collaborative Group.
Díaz R; Paolasso EA; Piegas LS; Tajer CD; Moreno MG; Corvalán R; Isea JE; Romero G
Circulation; 1998 Nov; 98(21):2227-34. PubMed ID: 9867443
[TBL] [Abstract][Full Text] [Related]
19. Glucose-insulin-potassium and reperfusion in acute myocardial infarction: rationale and design of the Glucose-Insulin-Potassium Study-2 (GIPS-2).
van der Horst IC; Timmer JR; Ottervanger JP; Bilo HJ; Gans RO; de Boer MJ; Zijlstra F;
Am Heart J; 2005 Apr; 149(4):585-91. PubMed ID: 15990738
[TBL] [Abstract][Full Text] [Related]
20. Challenges in the conduct of large simple trials of important generic questions in resource-poor settings: the CREATE and ECLA trial program evaluating GIK (glucose, insulin and potassium) and low-molecular-weight heparin in acute myocardial infarction.
Yusuf S; Mehta SR; Díaz R; Paolasso E; Pais P; Xavier D; Xie C; Ahmed RJ; Khazmi K; Zhu J; Liu L;
Am Heart J; 2004 Dec; 148(6):1068-78. PubMed ID: 15632895
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
